Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Exact Sciences Corporation logo

Exact Sciences Corporation

Sector: Healthcare   

Industry: Diagnostics & Research

69.06
 
USD
  
2.18
  
(3.26%)
Optionable: Yes  Market Cap: 11,843 M  90-day average vol: 2,011,908

Previous close: 66.88  Open: 67.18  Bid: 68.4  Ask: 72.0
52 week range    
56.05   
   100.77
Peers   
MYGN / 
IVC / 
ATRS / 
VCYT / 
BIOC / 
Last updated: Friday 29th March 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ATRS

1 B8.93.51

BIOC

0 B8.82.62

IVC

0 B-1.52.16

MYGN

2 B-30.225.7

SNY

VCYT

2 B-26.930.14
Financials

EXAS Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Amortization of intangibles-983000.03 M16 M93 M95 M97 M92 M
Basic EPS from continuing operations-1.25-1.71-1.63-0.99-1.43-0.64-5.61-3.48-3.54-1.13
Basic EPS total-1.71-1.63-0.99-0.64-5.61-3.48-3.54-1.13
Basic weighted shares outstanding80 M92 M102 M116 M122 M131 M151 M171 M176 M180 M
CommissionExpenses574 M
Cost of sales-4 M25 M-45 M-78 M-117 M-217 M-354 M459 M574 M654 M
Depreciation-2 M-4 M85 M100 M
Depreciation unreconciled-2 M-4 M-983000.03 M16 M93 M95 M97 M746 M
DepreciationAndAmortization-2 M-4 M-983000.03 M16 M93 M95 M97 M746 M
Diluted EPS total-1.25-1.71-1.63-0.99-1.43-0.64-5.61-3.48-3.54-1.13
Diluted normalized net income/share-1.25-1.71-1.63-0.99-1.43-0.64-5.61-3.48-3.54-1.13
Diluted weighted shares outstanding80 M92 M102 M116 M122 M131 M171 M176 M180 M
GainOnSaleOfSecurity542000.01 M2 M4 M21 M27 M7 M-10 M5 M
GeneralAndAdministrativeExpense-65 M-106 M-138 M-109 M178 M-352 M481 M801 M737 M893 M
Gross operating profit-3 M15 M54 M188 M338 M660 M1,137 M1,308 M1,510 M1,846 M
ImpairmentOfCapitalAssets-210 M
Income before tax-100 M-158 M-167 M-115 M-175 M-269 M-829 M-843 M-633 M-202 M
Income restructuring and M&A675 M238 M
Income taxes-187000.0-92000.0-185 M-5 M-247 M-9 M2 M
Interest income32 M
InterestExpenseNonOperating51000.06000.0213000.0206000.0-35 M-48 M-12 M19 M20 M19 M
MiscOtherSpecialCharges6 M7 M44000.068 M200000.0200000.032 M-19 M33 M
Net income from total operations-100 M-158 M-167 M-114 M-175 M-84 M-824 M-596 M-624 M-204 M
NetIncomeCommonStockholders-100 M-158 M-167 M-114 M-175 M-84 M-824 M-596 M-624 M-204 M
NetIncomeContinuousOperations-100 M-158 M-167 M-114 M-175 M-84 M-824 M-596 M-624 M-204 M
NetNonOperatingInterestIncomeExpense-51000.0-6000.0-213000.0-206000.0-37 M-51 M-17 M-19 M-20 M-19 M
Normalized income-61 M-103 M-109 M-115 M-200 M-464 M-1,095 M-2,428 M
Operating income-100 M-159 M-169 M-118 M-159 M-234 M-558 M-856 M-594 M-215 M
Operating income before depreciation (EBITDA)-96 M-149 M-111 M-100 M-89 M98 M-596 M-637 M-415 M24 M
OperatingExpense-98 M-174 M-223 M-306 M497 M-893 M-1,695 M2,144 M2,662 M2,714 M
Other income net-542000.0-1 M-2 M-4 M-21 M-16 M254 M-12 M35 M-32 M
Other special charges-11 M-51 M
OtherGandA-65 M-106 M-138 M-109 M178 M-352 M481 M801 M737 M893 M
OtherImpairmentOfCapitalAssets20 M16 M621000.0
OtherOperatingExpenses24 M-5 M13 M-78 M
OtherWriteOff4 M
PromotionAndAdvertising144 M170 M138 M
Research & development expense29 M34 M33 M-42 M67 M140 M-554 M386 M393 M426 M
ResearchExpense386 M393 M426 M
RestructringAndMnAIncome675 M238 M
Revenue per share-983000.03 M16 M93 M95 M97 M746 M
SalariesAndWages-27 M-80 M-108 M-138 M-220 M-200 M-298 M253 M207 M231 M
Selling Gen & administrative expense-68 M-136 M-190 M-263 M427 M-738 M1,071 M1,663 M2,158 M1,620 M
SellingAndMarketingExpense-2 M-30 M-51 M154 M249 M-385 M590 M862 M1,420 M727 M
Special income/charges-11 M-260 M-675 M-238 M
Total Income available for interest expense (EBIT)-100 M-158 M-122 M-114 M-138 M9 M-761 M-824 M-613 M-182 M
Total common shares outstanding89 M97 M111 M121 M126 M148 M169 M174 M178 M182 M
Total net income-100 M-158 M-167 M-114 M-175 M-84 M-824 M-596 M-624 M-204 M
Total ordinary shares182 M182 M182 M182 M182 M182 M182 M182 M182 M182 M
Total revenues2 M39 M99 M266 M454 M876 M1,491 M1,767 M2,084 M2,500 M
TotalExpenses102 M199 M268 M384 M614 M1,110 M2,427 M2,603 M3,236 M3,368 M
TotalRevenue2 M39 M99 M266 M454 M876 M1,491 M1,767 M2,084 M2,500 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University